# Ophthalmic and Topical Dosage Form New Animal Drugs; Enrofloxacin, Silver Sulfadiazine Emulsion
> **Food and Drug Administration** · Final rule. · Published 2000-11-07 · Effective 2000-11-07 · 65 FR 66619
## Document
- **Document number:** 00-28520
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 65 FR 66619
- **CFR reference:** 21 CFR 524
- **Publication date:** 2000-11-07
- **Effective date:** 2000-11-07
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Bayer Corp., Agriculture Division, Animal Health. The NADA provides for veterinary prescription use of an enrofloxacin/silver sulfadiazine otic emulsion to treat otitis externa in dogs.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2000/11/07/00-28520/ophthalmic-and-topical-dosage-form-new-animal-drugs-enrofloxacin-silver-sulfadiazine-emulsion)
---
*AI Analytics · CC0 1.0*